RHUMBLINE ADVISERS

Position in ROIV — Roivant Sciences Ltd.

CIK 1115418 BOSTON, MA

Position in ROIV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$41,717,342

+$10,879,874 QoQ

Shares Held

1,178,789

+5.9% QoQ

Ownership

0.163%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#63

of 489 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. ROIV ranks #7 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd. This page	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$41,717,342	1,178,789	+5.9%	Shares	Sole	2026-08-12
2026-03-31	$30,837,468	1,113,266	+7.3%	Shares	Sole	2026-05-12
2025-12-31	$22,516,592	1,037,631	+0.9%	Shares	Sole	2026-02-13
2025-09-30	$15,557,604	1,028,262	-0.1%	Shares	Sole	2025-11-06
2025-06-30	$11,604,696	1,029,698	-2.6%	Shares	Sole	2025-08-12
2025-03-31	$10,667,137	1,057,199	-1.7%	Shares	Sole	2025-05-29
2024-12-31	$12,718,326	1,075,091	-1.1%	Shares	Sole	2025-05-29
2024-09-30	$12,539,237	1,086,589	+22.6%	Shares	Sole	2024-11-12
2024-06-30	$9,370,231	886,493	-7.4%	Shares	Sole	2024-08-01
2024-03-31	$10,090,458	957,349	+127.1%	Shares	Sole	2024-05-09
2023-12-31	$4,735,028	421,641	+3.5%	Shares	Sole	2024-02-08
2023-09-30	$4,757,859	407,351	+35.7%	Shares	Sole	2023-11-09
2023-06-30	$3,025,008	300,100	—	Shares	Sole	2023-08-08
No filing history on record for this holder in this stock.